“CAR T-Cell Therapy Outcomes and Toxicity Profiles in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia” (2025) Annals of Leukemia Research, 6(1), pp. 10–15. doi:10.5281/zenodo.22238163.